ClinicalTrials.gov
public full text
Public Domain
BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women
The majority of HIV infected people worldwide became infected with the virus through heterosexual contact. BufferGel and PRO 2000 Gel are vaginal gels designed to prevent women from becoming infected with HIV during sexual intercourse with an HIV infected partner. This study will test the safety and effectiveness of these gels.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effectiveness of BufferGel as a Vaginal Contraceptive#894640
- Effectiveness of PeeRelease - a Gel Absorbent Pad in Moderate to Severe Urinary Incontinence#1094392
- Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.#1151320
- Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis#915002
- Safety Study of UC-781 Vaginal Microbicide#1113413
Record · ID 1138877
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive